Clinical Trial Update: Clinical Study on the Safety and Efficacy of Immunophenotyped Pancreatic Endocrine Organoid Bank in Treating Patients With T3c Diabetes [EARLY_Phase 1]

View source ↗

Summary

An EARLY Phase 1 clinical study is investigating the safety and efficacy of an immunophenotyped pancreatic endocrine organoid bank for treating Type 3c diabetes…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 3c Diabetes Mellitus

Drugs mentioned

• Immunophenotyped Pancreatic Endocrine Organoid Bank

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Diabetes Mellitus | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING